Together, our data indicate that CCR2 is an additional marker defining a subpopulation of migratory CD1c+ cDC enriched for CD64 expression in the blood and selectively enriched in the SF from patients with RA. This evidence concerns the gene CD1C and rheumatoid arthritis.